Senator Jean Shaheen has introduced a bipartisan bill to cap monthly insulin costs at $35 for Americans with employer-sponsored insurance. This move aims to make insulin more affordable for millions of Americans who rely on it to manage their diabetes.

The Need for Affordable Insulin

According to recent polls, health care costs are a major concern for many Americans, with one-third of Americans cutting back on expenses to afford health care. The high cost of insulin is particularly problematic, as it is a lifesaving medicine that many people cannot afford to cut back on.

The Inflation Reduction Act previously capped monthly insulin costs for Medicare beneficiaries, resulting in a significant decrease in out-of-pocket costs. However, this protection does not extend to Americans with private insurance, who often face high insulin costs.

A Bipartisan Solution

The proposed INSULIN Act would cap monthly insulin costs at $35 for Americans with employer-sponsored insurance, providing much-needed relief to families who struggle to afford this essential medicine. The bill has gained support from both Democrats and Republicans, with 13 senators from each party backing the legislation.

By capping insulin costs, Congress can take a significant step towards addressing the concerns of American families who are struggling to make ends meet. As Senator Shaheen notes, the success of the Medicare insulin cap offers a clear path forward for making insulin more affordable for all Americans.

Original reporting: Fox News (HLL/CB) — read the source article.